Advertisement
Research Article| Volume 319, ISSUE 1-2, P63-74, August 15, 2012

Distinctive clinicopathological features of 2 large families with amyotrophic lateral sclerosis having L106V mutation in SOD1 gene

      Abstract

      A clinicopathological study of 2 families with familial amyotrophic lateral sclerosis was previously reported [1]. The present study continues to investigate these families, with detailed clinical, genetic, and neuropathological studies performed on 24 patients, including 5 autopsy cases of the families. A point mutation at codon 106 (L106V) in the copper/zinc superoxide dismutase-1 (SOD1) gene was identified in the families. Average age at onset was 52.0±9.4 years, and initial symptoms were weakness and atrophy in the distal muscles of the lower extremities in most patients. Half of the patients showed neurogenic bladder (overactive bladder) and sensory impairment. The neurophysiological study showed peripheral/central conduction delay. Neuropathological examination revealed severe motor neuron loss with many bizarre reactive astrocytes in the spinal anterior horn. SOD1-immunopositive Lewy body-like hyaline inclusions and aggregation of neurofilaments were observed in the surviving anterior horn cells. Degeneration of the corticospinal tract was relatively minor. In addition, slight but diffuse gliosis was identified in the hypothalamus and medial nucleus of thalamus. Neurogenic bladder, sensory impairment, and degeneration of the hypothalamus and thalamus might be specific features in patients with familial amyotrophic lateral sclerosis with L106V mutation in the SOD1 gene.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tsukada N.
        • Fujimori N.
        • Oguchi K.
        • Tsukagoshi H.
        Clinicopathological studies on familial amyotrophic lateral sclerosis (in Japanese).
        Shinkeinaika. 1978; 9: 573-583
        • Dion P.A.
        • Daoud H.
        • Rouleau G.A.
        Genetics of motor neuron disorders: new insights into pathogenic mechanisms.
        Nat Rev Genet. 2009; 10: 769-782
        • Wijesekera L.C.
        • Leigh P.N.
        Amyotrophic lateral sclerosis.
        Orphanet J Rare Dis. 2009; 4: 3
        • Wroe R.
        • Wai-Ling Butler A.
        • Andersen P.M.
        • Powell J.F.
        • Al-Chalabi A.
        ALSOD: the amyotorophic lateral sclerosis online database.
        Amyotroph. Lateral Scler. 2008; 9: 249-250
        • Cudkowicz M.E.
        • McKenna-Yasek D.
        • Sapp P.E.
        • Chin W.
        • Geller B.
        • Hayden D.L.
        • et al.
        Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis.
        Ann Neurol. 1997; 41: 210-221
        • Juneja T.
        • Pericak-Vance M.A.
        • Laing N.G.
        • Dave S.
        • Siddique T.
        Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu, Zn superoxide dismutase.
        Neurology. 1997; 48: 55-57
        • Morita M.
        • Aoki M.
        • Abe K.
        • Hasegawa T.
        • Sakuma R.
        • Onodera Y.
        • et al.
        A novel two-base mutation in the Cu/Zn superoxide dismutase gene associated with familial amyotrophic lateral sclerosis in Japan.
        Neurosci Lett. 1996; 205: 79-82
        • Kohno S.
        • Takahashi Y.
        • Miyajima H.
        • Serizawa M.
        • Mizoguchi K.
        A novel mutation (Cys6Gly) in the Cu/Zn superoxide dismutase gene associated with rapidly progressive familial amyotrophic lateral sclerosis.
        Neurosci Lett. 1999; 276: 135-137
        • Aksoy H.
        • Dean G.
        • Elian M.
        • Deng H.X.
        • Deng G.
        • Juneja T.
        • et al.
        A4T mutation in the SOD1 gene causing familial amyotrophic lateral sclerosis.
        Neuroepidemiology. 2003; 22: 235-238
        • Kim N.H.
        • Kim H.J.
        • Kim M.
        • Lee K.W.
        A novel SOD1 gene mutation in a Korean family with amyotrophic lateral sclerosis.
        J Neurol Sci. 2003; 206: 65-69
        • Luigetti M.
        • Madia F.
        • Conte A.
        • Marangi G.
        • Zollino M.
        • Del Grande A.
        • et al.
        SOD1 G93D mutation presenting as paucisymptomatic amyotrophic lateral sclerosis.
        Amyotroph Lateral Scler. 2009; 10: 479-482
        • Perry J.J.
        • Shin D.S.
        • Getzoff E.D.
        • Tainer J.A.
        The structural biochemistry of the superoxide dismutases.
        Biochim Biophys Acta. 2010; 1804: 245-262
        • Kato S.
        Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences.
        Acta Neuropathol. 2008; 115: 97-114
        • Shibata N.
        • Hirano A.
        • Kato S.
        • Nagai R.
        • Horiuchi S.
        • Komori T.
        • et al.
        Advanced glycation endproducts are deposited in neuronal inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
        Acta Neuropathol. 1999; 97: 240-246
        • Cudkowicz M.E.
        • NcKenna-Yasek D.
        • Chen C.
        • Hedley-Whyte E.T.
        • Brown Jr., R.H.
        Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene.
        Ann Neurol. 1998; 43: 703-710
        • Takahashi H.
        • Makifuchi T.
        • Nakano R.
        • Sato S.
        • Inuzuka T.
        • Sakimura K.
        • et al.
        Familial amyotrophic lateral sclerosis with mutation in the Cu/Zn superoxide gene.
        Acta Neuropathol. 1994; 88: 185-188
        • Mochizuki Y.
        • Mizutani T.
        • Nakano R.
        • Fukushima T.
        • Honma T.
        • Nemoto N.
        • et al.
        Clinical features and neuropathological findings of familial amyotrophic lateral sclerosis with an H43R mutation in Cu/Zn superoxide dismutase (in Japanese).
        Rinsho Shinkeigaku. 2003; 43: 491-495
        • Ince P.G.
        • Shaw P.J.
        • Slade J.Y.
        • Jones C.
        • Hudgson P.
        Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide gene: pathological and immunocytochemical changes.
        Acta Neuropathol. 1996; 92: 395-403
        • Hays A.P.
        • Naini A.
        • He C.Z.
        • Mitsumoto H.
        • Rowland L.P.
        Sporadic amyotrophic lateral sclerosis and breast cancer: hyalin conglomerate inclusions lead to identification of SOD1 mutation.
        J Neurol Sci. 2006; 242: 67-69
        • Takehisa Y.
        • Ujike H.
        • Ishizu H.
        • Terada S.
        • Haraguchi T.
        • Tanaka Y.
        • et al.
        Familial amyotrophic lateral sclerosis with a novel Leu126Ser mutation in the copper/zinc superoxide dismutase gene showing mild clinical features and Lewy body-like hyaline inclusions.
        Arch Neurol. 2001; 58: 736-740
        • Fujimori N.
        • Kagaya H.
        • Yanagisawa N.
        • Tsukagoshi H.
        Epidemiologic investigation of motor neuron disease in the southern part of Nagano prefecture (in Japanese).
        Clin Neurol. 1979; 19: 91-97
        • Kawamata J.
        • Hasegawa H.
        • Shimohama S.
        • Kimura J.
        • Tanaka S.
        • Ueda K.
        Leu106Val (CTCGTC) mutation of superoxide dismutase-1 gene in patient with familial amyotrophic lateral sclerosis in Japan.
        Lancet. 1994; 343: 1501
        • Brooks B.R.
        • Miller R.G.
        • Swash M.
        • Munsat T.L.
        World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.
        Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 293-299
        • Yulug I.G.
        • Katsanis N.
        • de Belleroche J.
        • Collinge J.
        • Fisher E.M.
        An improved protocol for the analysis of SOD1 gene mutations, and a new mutation in exon 4.
        Hum Mol Genet. 1995; 4: 1101-1104
        • Rosen D.R.
        • Siddique T.
        • Patterson D.
        • Figlewicz D.A.
        • Sapp P.
        • Hentati A.
        • et al.
        Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.
        Nature. 1993; 362: 59-62
        • Vance C.
        • Rogelj B.
        • Hortobagyi T.
        • De Vos K.J.
        • Nishimura A.L.
        • Sreedharan J.
        • et al.
        Mutations in FUS, an RNA processing protein, cause familial amyptrophic lateral sclerosis type 6.
        Science. 2009; 323: 1208-1211
        • Sreedharan J.
        • Blair I.P.
        • Tripathi V.B.
        • Hu X.
        • Vance C.
        • Rojelj B.
        • et al.
        TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.
        Science. 2008; 319: 1668-1672
        • Battistini S.
        • Ricci C.
        • Lotti E.M.
        • Banigni M.
        • Gagliardi S.
        • Zucco R.
        • et al.
        Severe familial ALS with a novel exon 4 mutation (L106F) in SOD1 gene.
        J Neurol Sci. 2010; 293: 112-115
        • Valentino P.
        • Conforti F.L.
        • Pirritano D.
        • Nistico R.
        • Mazzei R.
        • Patitucci A.
        • et al.
        Brachial amyotrophic diplegia associated with a novel SOD1 mutation (l106P).
        Neurology. 2005; 64: 1477-1478
        • Kawata A.
        • Kato S.
        • Hayashi H.
        • Hirai S.
        Prominent sensory and autonomic disturbance in familial amyotrophic lateral sclerosis with a Gly93Ser mutation in the SOD1 gene.
        J Neurol Sci. 1977; 153: 82-85
        • Shimizu T.
        • Kawata A.
        • Kato S.
        • Hayashi M.
        • Takamoto K.
        • Hayashi H.
        • et al.
        Autonomic failure in ALS with a novel SOD1 gene mutation.
        Neurology. 2000; 54: 1534-1537
        • Athwal B.S.
        • Berkley K.J.
        • Hussain I.
        • Brennan A.
        • Craggs M.
        • Sakakibara R.
        • et al.
        Brain responses to changes in bladder volume and urge to void in healthy men.
        Brain. 2001; 124: 369-377
        • Yamamoto T.
        • Sakakibara R.
        • Uchiyama T.
        • Liu Z.
        • Ito T.
        • Yamanishi T.
        • et al.
        Lower urinary tract function in patients with pituitary adenoma compressing hypothalamus.
        J Neurol Neurosurg Psychiatry. 2005; 76: 390-394
        • Sumi H.
        • Kato S.
        • Mochimaru Y.
        • Fujimura H.
        • Etoh M.
        • Sakoda S.
        Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis.
        J Neuropathol Exp Neurol. 2009; 68: 37-47
        • Ohi T.
        • Nabeshima K.
        • Kato S.
        • Yazawa S.
        • Takechi S.
        Familial amyotrophic lateral sclerosis with His46Arg mutation in Cu/Zn superoxide dismutase presenting characteristic clinical features and Lewy body-like hyaline inclusions.
        J Neurol Sci. 2004; 225: 19-25
        • Arisato T.
        • Okubo R.
        • Arata H.
        • Abe K.
        • Fukuda K.
        • Sakoda S.
        • et al.
        Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families.
        Acta Neuropathol. 2003; 106: 561-568
        • Shaw C.E.
        • Enayat Z.E.
        • Powell J.F.
        • Naderson V.E.
        • Radunovic A.
        • al-Sarraj S.
        • et al.
        Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD1 mutation.
        Neurology. 1997; 49: 1612-1616
        • Tan C.F.
        • Piao Y.S.
        • Hayashi S.
        • Obata H.
        • Umeda Y.
        • Sato M.
        • et al.
        Familial amyotrophic lateral sclerosis with bulbar onset and a novel Asp101Tyr Cu/Zn superoxide gene mutation.
        Acta Neuropathol. 2004; 108: 332-336
        • Kawamata C.
        • Morita M.
        • Shibata N.
        • Nakano I.
        Familial amyotrophic lateral sclerosis (FALS) with a novel SOD1 gene mutation: a clinicopathological study (in Japanese).
        Rinsho Shinkeigaku. 2007; 47: 211-216
        • Getzoff E.D.
        • Tainer J.A.
        • Stempien M.M.
        • Bell G.I.
        • Hallewell R.A.
        Evolution of CuZn superoxide dismutase and the Greek key beta-barrel structural motif.
        Proteins. 1989; 5: 322-336
        • Liu J.
        • Lillo C.
        • Jonsson P.A.
        • Vande Velde C.
        • Ward C.M.
        • Miller T.M.
        • et al.
        Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria.
        Neuron. 2004; 43: 5-17
        • Reaume A.G.
        • Elliott J.L.
        • Hoffman E.K.
        • Kowall N.W.
        • Ferrante R.J.
        • Siwek D.F.
        • et al.
        Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury.
        Nat Genet. 1996; 13: 43-47
        • Gurney M.E.
        Transgenic animal models of familial amyotrophic lateral sclerosis.
        J Neurol. 1997; 244 (Suppl.): S15-S20
        • Ince P.G.
        • Wharton S.B.
        Chapter 5 cytopathology of the motor neuron.
        Handb Clin Neurol. 2007; 82: 89-119
        • Deng H.X.
        • Hentati A.
        • Tainer J.A.
        • Cayabyab A.
        • Hung W.Y.
        • Getzoff E.D.
        • et al.
        Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase.
        Science. 1993; 261: 1047-1051
        • Inoue K.
        • Fujimura H.
        • Ogawa Y.
        • Satoh T.
        • Shimada K.
        • Sakoda S.
        Familial amyotrophic lateral sclerosis with a point mutation (G37R) of the superoxide dismutase 1 gene: a clinicopathological study.
        Amyotroph Lateral Scler Other Motor Neuron Disord. 2002; 3: 244-247
        • Kobayashi Z.
        • Tsuchiya K.
        • Kubodera T.
        • Shibata N.
        • Arai T.
        • Miura H.
        • et al.
        FALS with Gly72Ser mutation in SOD1 gene: report of a family including the first autopsy case.
        J Neurol Sci. 2011; 300: 9-13
        • Suzuki M.
        • Irie T.
        • Watanabe T.
        • Mikami H.
        • Yamazaki T.
        • Oyanagi K.
        • et al.
        Familial amyotrophic lateral sclerosis with Gly93Ser mutation in Cu/Zn superoxidate dismutase: a clinical and neuropathological study.
        J Neurol Sci. 2008; 268: 140-144
        • Kawamoto Y.
        • Akiguchi I.
        • Fujimura H.
        • Shirakashi Y.
        • Honjo Y.
        • Sakoda S.
        14-3-3 proteins in Lewy body-like hyaline inclusions in a patient with familial amyotrophic lateral sclerosis with a two-base pair deletion in the CU/Zn superoxide dismutase (SOD1) gene.
        Acta Neuropathol. 2005; 110: 203-204
        • Kato S.
        • Saeki Y.
        • Aoki M.
        • Nagai M.
        • Ishigaki A.
        • Itoyama Y.
        • et al.
        Histological evidence of redox system breakdown caused by superoxide dismutase 1 (SOD1) aggregation is common to SOD1-mutated motor neurons in humans and animal models.
        Acta Neuropathol. 2004; 107: 149-158
        • Murayama S.
        • Namba E.
        • Nishiyama K.
        • Kitamura Y.
        • Morita T.
        • Nakashima K.
        • et al.
        Molecular pathological studies of familial amyotrophic lateral sclerosis.
        Neuropathology. 1997; 17 (Suppl): 219